Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

CKD-L, an HDAC6 inhibitor, may have potential for the treatment of RA

June 18, 2014

Rheumatoid arthritis candidate BI-638683 well tolerated in phase I study

June 18, 2014

Novel PIKfyve inhibitor described by Astellas scientists

June 17, 2014

Oncobiologics begins phase I trial of biosimilar ONS-3010

June 16, 2014

Revive Therapeutics submits pre-IND package to the FDA for REV-002

June 10, 2014

Protalex reports new data analysis from phase Ib study of PRTX-100 for rheumatoid arthritis

June 6, 2014

UCB Celltech initiates phase I trial in patients with psoriatic arthritis

May 30, 2014

Janssen withdraws application for intravenously administered Simponi in E.U.

May 23, 2014

Antibe Therapeutics submits CTA for ATB-346

May 22, 2014

New BTK inhibitors patented by Roche

May 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...